In a mouse model of PIK3CA-related epilepsy expressing the most common human mutations and which recapitulates the human phenotype, a new inhibitor of PI3K signaling that is being trialed for solid tumors (BKM120, a 2,6-dimorpholino pyrimidine derivative) significantly increased the seizure threshold (29). Here, PIK3CA is linked to epilepsy.